Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Testing effectiveness (Phase 2)Study completedNCT02527434What this trial is testingStudy of Tremelimumab in Patients With Advanced Solid TumorsWho this might be right forUrothelial Bladder CancerTriple-negative Breast CancerPancreatic Ductal Adenocarcinoma AstraZeneca 64
Early research (Phase 1)Looking for participantsNCT06293898What this trial is testingOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsWho this might be right forEndometrial CancerCervical CancerOvarian Cancer+7 more SystImmune Inc. 280
Early research (Phase 1)Looking for participantsNCT07623369What this trial is testingA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Huahui Health 299
Testing effectiveness (Phase 2)Study completedNCT00055835What this trial is testingS0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumWho this might be right forBladder CancerUrethral Cancer SWOG Cancer Research Network 7
Early research (Phase 1)UnknownNCT06094777What this trial is testingHY-0102 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Shanghai YingLi Pharmaceutical Co. Ltd. 50
Not applicableStudy completedNCT04566029What this trial is testingEvolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial CarcinomasWho this might be right forUrothelial Carcinoma Centre Hospitalier Universitaire de Nīmes 40
Testing effectiveness (Phase 2)Looking for participantsNCT07287995What this trial is testingASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsWho this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 428
Testing effectiveness (Phase 2)Looking for participantsNCT07186842What this trial is testingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Who this might be right forAdvanced Solid Cancers BioNTech SE 245
Early research (Phase 1)Study completedNCT04773951What this trial is testingA Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid TumorsWho this might be right forMelanomaRenal CarcinomaUrothelial Carcinoma Shanghai Junshi Bioscience Co., Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT03679767What this trial is testingINCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Who this might be right forMetastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more Incyte Corporation 121
Testing effectiveness (Phase 2)Looking for participantsNCT06760819What this trial is testingLearn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Solid TumorsHER2 Mutation Bayer 111
Not applicableEnded earlyNCT05568407What this trial is testingAvelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial CancerWho this might be right forBladder Cancer Pfizer 19
Testing effectiveness (Phase 2)Study completedNCT01711112What this trial is testingSalvage Docetaxel for Pretreated Urothelial CancerWho this might be right forBladder Cancer Samsung Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04848519What this trial is testingImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial CarcinomaWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+11 more Emory University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07048457What this trial is testingConsolidative Local Therapy (CLT) in Oligo-metastatic Urothelial CarcinomaWho this might be right forLocally Advanced Urothelial CarcinomaOligo-metastaic Urothelial Carcinoma Yale University 32
Early research (Phase 1)Study completedNCT06894771What this trial is testingMK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)Who this might be right forMalignant Neoplasm Merck Sharp & Dohme LLC 5
Testing effectiveness (Phase 2)Study completedNCT00151034What this trial is testingTrastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerWho this might be right forUrologic Neoplasms University of Michigan Rogel Cancer Center 33
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198
Not applicableEnded earlyNCT04106167What this trial is testingLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyWho this might be right forAdvanced Solid TumorLymphomaGastric Cancer+15 more Fate Therapeutics 20